DNA methylation dynamics in the genome
Epigenomic profiling of multiple tissues and many disease states has enhanced drug discovery programs, cancer diagnosis and analysis, population based studies and regenerative medicine. The relative ease of genomic mapping of DNA methylation was facilitated by an epigenetic mark that is highly stable and can be retrieved from archival samples [1] [2] [3] [4] . Genomic DNA methylation profiles are tissue specific hallmarks of cell identity [5] . The modification occurs at the 5th position of cytosine to generate 5-methylcytosine (5mC), typically in the context of the dinucleotide CpG on both DNA strands. In somatic tissues >70% of CpGs are constitutively methylated [6] . The propagation and maintenance of DNA methylation patterns during development, by combined action of DNA methyltransferases (DNMTs) and DNA demethylation pathways, creates an epigenetic 'landscape' that supports cell type specific gene regulatory networks, regulates imprinted gene activity, represses transposon activity and enhances genome integrity [6] .
DNA methylation is an epigenetic repressive mark in regulatory regions (gene promoters and enhancers), generally associated with their functional inhibition as determined by sequence context [6, 7] . DNA methylation reprogramming can result from inhibition of DNMTs or de novo DNMT activity. In addition, TET enzymes contribute to DNA methylation dynamics by oxidation of 5mC to 5-hydroxymethylcytosine (5hmC), 5-formylcytosine (5fC) and 5-carboxylcytosine (5caC) as intermediates in DNA demethylation pathways. These additional DNA modifications may also act as unique epigenetic signals ( Figure 1a ) [8] . Although 5hmC, 5fC and 5caC are less abundant than 5mC, they contribute to a sensitive and dynamic read-out of cell state, as their profiles are in part determined by active gene-body transcription and enhancer activity, which are rapidly altered upon environmental challenge [8,9 ,10] . 5mC profiles can exhibit age associated changes that may predicate more dramatic changes upon cellular transformation [11] (Figure 1b ). Conversely, 5hmC profiles, in concert with other epigenomic profiles, are a highly useful tool for charting environmental exposure and integrated pathway analysis to reveal a drug's mode of action (MoA) [12] (Figure 2 ).
DNA modification 'barcoding' in risk assessment
In an environmental exposure context, a baseline of epigenomic profiles (including transcription) for the target tissue in the organism can be used as a starting point for dose-response, temporal and transient exposure studies with model compounds (inorganic Arsenic, Vinclozolin and Triclosan) ( Figure 2 ) [13] . It is essential to use models that can be extrapolated to humans, as responses to a drug or environmental challenge may be species specific [13] . Furthermore environmental epigenetics has to be allied with classical toxicology studies in order to be fully informative [14 ,15 ] Elucidating the xenobiotic-induced physiological changes in animal models and human cohorts is important for hazard (including cancer) identification and risk assessment [13, 16] . Concern over bio-reactive chemical and environmental agents has led to better understanding of the MoAs underlying toxic effects of chemical exposure [17] . Testing of chemicals depends on long-term rodent bioassays, which are costly and time-consuming, especially dose response studies to evaluate minimal observed adverse effect levels as points of departure (PoD) for hazard assessment. Recent progress has demonstrated that the integrated analysis of combined gene expression and epigenetic profiling of target tissues in model organisms exposed to chemical compounds can reveal underlying MoAs, and may act as predictors of atypical endpoints and adverse outcome pathways (AOPs) where cellular homeostasis is over-ridden [18, 19] . The application of epigenomics profiling in concert with bioassays can further inform decisions in chemical risk assessment by identifying the critically sensitive biological pathways. As epigenomic signatures can be propagated through cell divisions, they can potentially persist even after removal of the exposure agent [20] . However, altered epigenomic profiles may also signify changes in cellular populations, altered by exposure [3] . This record of chronic epigenomic alterations induced by multiple environmental exposures may be interpreted in terms of a 'barcode/identifier' of risk and consequences that can be developed into alternative screening systems, such as microfluidic organs-on-a-chip technologies [20, 21] .
5hmC mapping: a tool to link exposure events to disease states A wealth of data has recorded changes in transcriptional states following compound exposure [22] . However, due to the highly dynamic nature of transcriptional changes following chemical exposure, it is challenging to tell cause from effect in these studies. The application of dynamic 5hmC profiling can enhance the information extracted from exposure studies, especially if it can be performed on archived material and integrated with previous data profiles. 5hmC patterns are linked with gene expression status and can rapidly alter following short term (24 hours) exposure -highlighting the sensitivity of such assays [9 ] . 5hmC alterations are linked to the length of drug exposure, and a number of 5hmC changes induced by the non-genotoxic carcinogen, phenobarbital (PB), were shown to persist in PB driven tumours, highlighting that such changes may be early exposure biomarkers [13] . It is also noteworthy that in age associated DNA methylation signatures, identified in humans and mice, attenuation of these changes by altered diet is associated with increased longevity [11, 23] . Thus, it may be possible to decode 5hmC signatures that are unique to a given drug exposure/disease state, in which loci exhibiting reproducible 5hmC changes can be predictive of downstream consequences. 5hmC profiles in circulating cell free DNA can already aid in the identification of the tissue origin of tumours based on their abnormal DNA modification profiles [24 ] . The large scale application of genomewide sequencing approaches in these studies will lead to a greater understanding of the molecular events occurring following compound exposure and toxicity, enabling a more defined study of linkage to disease outcomes.
Studies of DNA methylation patterns following environmental and chemical exposure events in humans
The majority of studies interrogating epigenetic response have been highly targeted approaches, such as locus The methylome as a marker of cell state. (a) In the proposed mammalian DNA methylation pathway, canonical methylcytosine (5mC) is formed by addition of a methyl group to unmodified cytosine by DNA methyltransferase enzymes (DNMTs). Members of the TET family of di-oxygenases can then convert 5mC to 5-hydroxymethylcytosine (5hmC), using iron and a-ketoglutarate as cofactors. The DNA methylation cycle is completed by conversion of 5hmC to unmodified cytosine by (i) passive de-methylation upon DNA replication as methyltransferases do not recognise hydroxymethylated DNA, or (ii) TET-mediated oxidation of 5hmC to 5-formylcytosine (5fC) and then carboxyl-cytosine (5caC), followed by their removal through base-excision repair. (b) The development of epigenetic identity in mammalian cells reflects the establishment and activity of underlying gene regulatory networks (GRNs) that specify epigenetic transitions in dynamic and reversible systems that become more restricted as development proceeds. specific sequencing following bisulphite treatment or candidate locus specific PCR following epigenetic antibody enrichment strategies [15 ,25 ] . Progress in the assessment is summarised here and in Table 1 . The harmful effects of endocrine disrupting chemicals (EDCs) in the environment are based on their ability to act as endogenous hormone mimics [15 ] . Multi-layered epigenomic analysis combined with toxicological assessments such as the EDC tests provided by the Organisation for Economic Co-operation and Development (OECD) will improve exposure monitoring and derive endpoints that are predictive/protective of all life stages in different organisms, which may have altered dependencies on epigenomic pathways [32 ,33] . The mode of action of EDCs is not only through reproduction impairments [15 ] ; many liver specific cytochrome P450 detoxification enzymes are induced by and metabolise a broad range of steroidal and EDC compounds, leading to perturbed transcriptional and epigenetic outcomes [34] . Recent studies on the antibacterial agent, Triclosan, for instance suggest it may alter the liver methylome and act as a tumour promoter [35, 36] . Comprehensive epigenomic modelling of the effect of toxic compounds and EDCs on the liver in multiple organisms can therefore underpin environmental exposure epigenetic studies; a generic experimental design is outlined in Figure 2 .
Studies investigating drug induced epigenetic perturbations have focused on exposure to carcinogenic agents in rodent bioassays either by genotoxic carcinogens (GCs) or non-genotoxic carcinogens (NGCs). NGCs are able to promote carcinogenesis without inducing a direct mutation to the DNA sequence and thus can be viewed as inducers of changed epigenetic states that are propagated long after the initial exposure event [13, 37] . PB is a wellestablished model of a non-genotoxic rodent hepatocarcinogen increasing the incidence of spontaneously and DNA methylation as a genomic marker Meehan et al. 51 Table 1 Environmental and chemical exposure studies.
Exposure

Mode of action Areas of uncertainty References
Heavy metals: arsenic, cadmium Differentially methylated regions detected following exposure in cultured cells correlate with changes in gene expression, alternative splicing, epithelial to mesenchymal transition; differential methylation in T-cells; altered p16 expression. chemically induced liver tumours [38] . Previous work has shown that exposure to certain xenobiotic agents such PB results in reproducible changes in both the epigenome and transcriptome in both mouse and rat livers in a time dependent manner -ultimately resulting in genetically defined liver tumour formation (Figure 3 ) [39 ] . Comparative analyses of these omics landscapes provides a novel insight into the molecular events and perturbation of gene networks following both acute and chronic exposure events providing early biomarkers for the development of AOPs such as tumour formation [13] .
Another area that requires deeper study is the analysis of compounds implicated in germline changes causing transgenerational outcomes [40, 41] . Many groups have shown that the sperm methylome can be perturbed by environmental influences including diet; however, stochastic epigenetic variation can affect the mouse sperm methylome to a greater extent than diet and would be hard to reconcile with specific transgenerational outcomes that depend on fertilization by a single sperm [42 ,43] . Vinclozolin, an anti-androgenic fungicide, is suggested to induce transgenerational phenotypes associated with perturbed epigenetic profiles [40, 41] . However, independent groups were unable to replicate the phenotypic results following intraperitoneal or oral exposure routes [44] [45] [46] , perhaps due to genetic variability in rat strains and other factors. In a genome wide methylation study of prospermatogonia of male offspring from mothers treated with vinclozolin, bisphenol A, or di-(2-ethylhexyl)phthalate, changes in transcription and methylation in the G1 germline observed after EDC exposure did not persist into the G2 germline [47 ] . This suggests that EDCs can exert direct epigenetic effects in exposed fetal germ cells, but these may be corrected by reprogramming events in the next generation which protect against transgenerational outcomes.
T-cell methylation as an optimal barcode of environmental and chemical exposure in humans
An ideal biomarker should be sensitive, specific, accessible, cause minimal discomfort to the patient and be robust to variations in laboratory handling. DNA methylation fulfils many of these criteria. However, although several chemical and environmental agents are known to affect the DNA methylation profiles of mammalian tissues, profiling in vivo methylation at internal sites of environmental insult is rarely possible. CD4 + T-cells patrol the entire human body, including the central nervous system, and upon exposure to their cognate antigen differentiate into short-lived effector T-cells or long-lived memory Tcells [55] . Importantly, as the chemical micro-environment of T-cells at the time of activation can affect their epigenetic profile [31,48-53,54 ,56] , memory T-cells can carry epigenetic markers of both the type and location of exposure to chemical or environmental agents [57, 58] . Moreover, as these cells can live for up to 40 years, our memory T-cell population carries a collective epigenetic record of our total environmental and chemical exposure over time (Figure 4 ).
Several studies have reported consistent alterations in T-cell methylation resulting from environmental or 52 Chemical genetics and epigenetics 
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The methylome as sensor of environmental injury. Numerous natural and non-natural environmental agents have been shown to induce changes in DNA methylation in various tissues in vivo, some with correlated changes in gene expression (e.g. Cyp2b and PTPRJ). The stable maintenance of these altered epigenetic patterns (based on Refs. [12, 27, 29] ) ensures that a memory of this exposure remains, long after the initiating signal is gone. Different colours represent target tissues.
chemical exposure to many of the agents reviewed above.
Smoking, air pollution (polycyclic aromatic hydrocarbons, and ambient fine particles) [31, 53] , arsenic [48] [49] [50] , pollen [54 ] , milk protein [56] and certain vitamins [53] have been associated with altered CD4 + T-cell methylation, at the time of exposure and afterwards [54 ] . The observed changes in T-cell methylation or in T-cell population composition may result from direct effects upon the differentiation program of the T-cells or from their response to tissue injury, or both. Thus, whereas methylation profiles of total CD4 + T-cell populations may identify large changes in DNA methylation induced by exposure to chemical and non-chemical environmental agents [54 ] , the ability to profile thousands of single T-cell methylomes simultaneously will allow identification of individual sub-populations of memory T-cells that may have been affected by different exposures at different time points; this complex information may be codified into an epigenetic barcode of system-wide and organspecific historical environmental and chemical exposures (Figure 4 ).
Future perspectives
The application of integrated epigenomic and transcriptomic profiling of xenobiotic exposure in animal models has enabled enhanced mechanistic interpretation and novel early biomarker discovery [12,13,59 ,60] . To assess the relevance of epigenetic modifications identified in vitro for drug safety science, it is essential to investigate such changes in putative target organs in vivo. To determine the epigenetic changes that signify a toxic response, one of the future challenges will be in understanding the mechanisms by which these dynamic multi-dimensional epigenetic landscapes are regulated and altered in response to chemical exposure [14 ] . It is therefore essential to establish both the dose response, particularly at low exposures, and reversibility, to aid risk assessment and dose setting (Figures 2 and 4) . Another challenge will be understanding how toxicant exposure affects the composition and differentiation status of cell types in a given tissue -which may be addressed through the adaptation of new technologies such as single cell transcriptomic and epigenomic analyses. Progress in these areas will require interdisciplinary research encompassing toxicology, epigenomics data generation, bioinformatics and clinical and whole animal studies. Out-standing paper that utilizes 5-hydroxymethylcytosine (5hmC) as a diagnostic identifier in circulating cell-free DNA (cfDNA) of cancer patients. They found distinct features that could be used to predict cancer types and stages with high accuracy. The authors suggest that cell-free 5hmC signatures may potentially be used not only to identify cancer types but also to track tumour stages. Similar methodologies may be utilised in chemical challenge studies perhaos using specific T-cell populations as the target tissue.
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